Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.87 USD | -3.98% | 0.00% | -38.77% |
May. 15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
May. 14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.77% | 187M | |
+8.92% | 114B | |
+10.48% | 105B | |
-6.45% | 23.83B | |
-3.61% | 21.73B | |
-10.39% | 18.1B | |
-42.36% | 16.34B | |
-14.45% | 16.13B | |
+3.76% | 13.75B | |
+28.94% | 11.76B |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Capital One Starts Fennec Pharmaceuticals at Overweight With $11 Price Target